World tasked

Angiotech Pharmaceuticals,
Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and
medical device company, announced that the U.S. Food and Sedative
Administration (FDA) has given space to begin marketing the
Hemo-Stream(TM) dyed in the wool dialysis catheter.

The Hemo-Stream catheter, developed by Rex Medical, LP, is the first
chronic hemodialysis catheter specifically designed for over with-the-wire
delivery. Its advantages list higher flow rates payable to its triple lumen
map, reduced covert for air embolism or bleeding, decreased
procedural steps and one day versus competition, and assuage of catheter
placement. Dialysis catheters, such as Hemo-Beck, are used conducive to short term
vascular access to attend to arrange for hemodialysis patients with the dialysis they
require.

In April 2007, Angiotech entered into an compact with Rex Medical
whereby Rex Medical granted Angiotech an sole license to demand and
distribute the Hemo-Tide catheter worldwide.

“The Hemo-Brooklet catheter is a basic complement to the vascular graft
business we acquired from Edwards and our Vascular Wrap AV access trials
which are currently enrolling,” said Dr. William Nimrod, President and CEO
of Angiotech. “With upward of 500,000 End Stage Renal Disease patients in the
U.S., Angiotech is focused on the maturing and commercialization of
innovative dialysis care products that improve the treatment options
at to hemodialysis patients and vascular surgeons.”

It is expected that Hemo-Cataract catheters will be available for
commercial sale in the U.S. later this year.

In all directions Rex Medical, LP

Rex Medical, LP, based in Conshohocken, PA, is a privately held medical
device group specializing in the unfolding, manufacturing and marketing
of minimally invasive medical devices targeted towards the cardiovascular,
venous access, endosurgery and oncology markets.

Note on Advance Looking Statements

Statements contained in this hurry release that are not based on
real fact, including without limitation statements containing the
words “believes,” “may,” “plans,” “will,” “estimate,” “continue,”
“anticipates,” “intends,” “expects” and similar expressions, constitute
“forward-looking statements” within the meaning of the U.S. Reclusive
Securities Legal remedy Reform Act of 1995 and constitute “forward-looking
information” within the meaning of applicable Canadian securities laws. All
such statements are made pursuant to the “safe harbor” provisions of
suited securities legislation. Forward-looking statements in this
release categorize but are not narrow to statements anyhow; financial
benefits to Angiotech that could potentially be realized from Angiotech’s
sale of the Hemo-Stream merchandise, the ability of Angiotech to commercialize
the Hemo-Stream product and to develop and commercialize any continual
consequence lines, that a substantial market exists for the product, and that
the spin-off resolve mount as expected. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that may
induce the actual results, events or developments to be basically different
from any time to come results, events or developments expressed or implied by
such forward-looking statements. Varied such risks, uncertainties and other
factors are taken into account as part of our assumptions underlying these
into the open-looking statements and include, among others, the following;
general fiscal and business conditions, both nationally and in the
regions in which we handle; market insist on; technological changes that
could hit our existing products or our skills to develop and
commercialize future products; championship; existing governmental
regulations and changes in, or the lemon to comply with, governmental
regulations; decisions, and the timing of decisions, made by health
regulatory agencies regarding approval of our technology and products; the
requirement by reason of substantial funding to conduct probe and maturity and
to expand commercialization activities; and any other factors that may
affect exhibit. In addition, our business is dominate to certain
operating risks that may reason the true to life results expressed or implied by
the forward-looking statements in this report to differ materially from our
factual results. These operating risks take in; poor performance of the
product in the clinical home; adverse events related to the use of the
product; uncalled-for estimate of the extent of the market for the artefact;
adverse results or unexpected delays in clinical development processes; our
ability to attract and impress on the memory talented personnel; our capability faculty to
successfully absolute preclinical and clinical phenomenon of our products;
changes in house procedure or development plans; our failure to be prevalent
patent protection for discoveries; collapse of palpable protection resulting from
third party challenges to our patents; commercialization limitations
imposed by patents owned or controlled by third parties; our ability to
obtain rights to technology from licensors; exposure on patent claims and
other claims asserted against us; our facility to obtain and support timely
patent and other scholar land guardianship into our technology and
products; the ability to enter into, and to maintain, corporate alliances
relating to the maturation and commercialization of our technology and
products; market acceptance of our technology and products; our skill to
successfully manufacture, market and sell our products; the continued
availability of leading to bankroll our activities; and any other factors
referenced in our annual information turn out and other filings with the
applicable Canadian securities regulatory authorities or the SEC.

Comprar viagra espana

Given these uncertainties, assumptions and risk factors, readers are
cautioned not to town undue confidence on such brazen-looking statements.
We disclaim any bond to update any such factors or to publicly
announce the result of any revisions to any of the forward-looking
statements contained in this outline to bring future results, events
or developments.

Hemo-Stream(TM) is a trademark of Rex Medical, LP used under license by
Angiotech.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical
and medical device concern with all through 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for the sake diseases
or complications associated with medical device implants, surgical
interventions and acute outrage. To find out more about Angiotech (NASDAQ:
ANPI, TSX: ANP), suit take in our website at http://www.angiotech.com.

Angiotech Pharmaceuticals, Inc.
http://www.angiotech.com

Following the ad by officials in South Korea of another bird flu outbreak, 5.3 million birds are expected to be culled to control the spread of the deadly virus.

This latest outbreak in South Korea is the 17th case of bird flu in three weeks and is the country’s fastest and biggest ever outbreak of avian influenza.

Officials at the Ministry for Food, Agriculture, Forestry and Fisheries say that the case which tested positive for the H5N1 virus, appeared on a chicken farm in Jeongeup, in North Jeolla province, four kilometers away from the area where the nation’s third case of bird flu for this year was reported.

Although most of the cases had been concentrated in South and North Jeolla provinces, in South Korea’s southeastern area, a recent outbreak in Pyeongtaek, 70 kilometers from Seoul, raised concerns that bird flu might be spreading rapidly across the country.

Since the beginning of April South Korea has culled 4.86 million chickens and ducks as the highly virulent H5N1 strain of the virus, which first appeared in the southwest, has now surfaced in five provinces.

According to the agriculture ministry all of the country’s 260 duck farms will be checked as a preemptive measure and quarantines and restrictions will continue.

The military has become involved with soldiers drafted to the Jeolla province in the north which has been badly affected, to help with the culling process and the disposal of the birds.

To date South Korea has been forced to kill 5.29 million birds in its first outbreak in late 2003 and early 2004, and about half that number were culled in the second outbreak in 2006-2007.

At present, according to World Health Organisation, no human deaths from the disease have been reported in South Korea but worldwide 240 human deaths have occurred of 381 confirmed cases of infection since 2003.

The ministry has estimated that the bird flu outbreak has inflicted $30 billion in damages as millions of birds have been culled and buried and falling demand for both chicken and duck meat has also affected the poultry industry.

Skipping breakfast and snacking on sugary and fatty foods could be fuelling Britain’s rising portliness rates among the beneath the waves 25s.

A new survey commissioned by Cancer Research UK into the nation’s breakfast habits discovered that nearly half the 16-24 age group miss breakfast - the first and most important meal of the day - at least twice a week.

The survey, commissioned to raise awareness of the charity’s annual Britain’s Biggest Breakfast campaign, also showed that 85 per cent of under 25s questioned admitted to snacking, with fatty and sugary foods, such as crisps, biscuits, cakes and sweets favourites to keep mid-morning hunger at bay.

Professor Jane Wardle, director of Cancer Research UK’s health behaviour research centre, said: “There is still widespread ignorance that being overweight or obese increases the risk of a number of cancers. We know obesity rates are rising in the UK and research has shown that this trend begins early in life.

“Children who are overweight or obese are likely to grow into obese adults whose risk of cancer and other diseases is increased because of the extra weight they are carrying. This survey reflects the worrying trend that too many young people miss breakfast only to resort to sugary and fatty snacks when they get hungry. These habits can be hard to break.”

Cancer Research UK carried out the survey of over 2,000 people to promote Britain’s Biggest Breakfast. The charity is calling for people across the UK to celebrate Britain’s Biggest Breakfast’s tenth anniversary by throwing a breakfast ‘party’ to raise money for research into all types of cancer.

TV presenter Amanda Hamilton, one of the UK’s leading nutritionists and Britain’s Biggest Breakfast supporter, said: “A healthy breakfast is important as part of a balanced diet and is an excellent way to start the day.

“This campaign is a great way of showing both parents and kids that healthy eating isn’t boring and hopefully it will encourage families to all sit down and eat breakfast together.”

Among those that skip breakfast, more than a third (37 per cent) claim the reason is lack of time.

But there is some good news about Britain’s breakfast habits. Only four percent of people opt for the traditional cooked breakfast. Instead, more than half (57 per cent) opted for cereal or porridge and a further 16 per cent chose toast as their preferred start to the day.

Experts estimate that about a quarter of all cancer deaths are caused by unhealthy diets and obesity. The event aims to show people how eating a healthy breakfast, as part of a balanced diet including plenty of fruit and vegetables, can help reduce your risk of cancer.

http://www.cancerresearchuk.org/

The Food and Drug Charge (FDA) is implementing a nationwide information stump to give rise to awareness at hand the resources accessible to address questions related to the benefits and risks of hormone therapy for menopausal symptoms.

According to Census data from 2000, there are about 37.5 million women reaching or currently at menopause (ages 40 to 59). FDA wants women to be informed about new and emerging safety information about menopausal hormone treatment.

“Menopausal hormone therapy like all medications has benefits and risks which is why it is important for FDA to provide the latest, most helpful information to assist women in making the best decision to fit their needs,” said Dr. Susan Wood, Assistant Commissioner of FDA’s Office of Women’s Health. She continued, “FDA’s main message is: If you choose to use hormones for treating symptoms of menopause, use them at the lowest dose that helps for the shortest time needed.”

The FDA and its partners are working to distribute education materials to help women make informed decisions about their health. These materials address questions of concern to perimenopausal and menopausal women considering the use of hormone therapy for relief of their symptoms. This science-based information has been developed in collaboration with the National Institutes of Health and other agencies of the Department of Health and Human Services.

The campaign helps clarify the National Institutes of Health findings from their landmark Women’s Health Initiative (WHI) studies about the benefits and risks of menopausal hormone therapy. This research dramatically changed the previous knowledge base about use of hormone therapy. Women now have questions about what these findings mean for them.

The conclusions from WHI clinical studies showed that women using estrogen with or without progestin may increase their chances of strokes and blood clots. Using estrogen with progestin also increased a woman’s chance of getting breast cancer and heart attacks, but using estrogen alone did not. For women with a uterus on hormone therapy, a combination of estrogen plus progestin is prescribed. Progestin prevents the overgrowth of the lining of the uterus, which can lead to cancer, a known risk of estrogen. For women who have had a hysterectomy, hormone therapy consists of estrogen alone. Using estrogen with or without progestin may increase the risk of dementia in women age 65 years or older. Estrogen, either alone or with progestin, decreased women’s chances of developing weak bones. Estrogen with progestin decreased the risk of colorectal cancer in women.

http://www.fda.gov

Plumpness is associated with a 25 percent increase in the jeopardy of developing feeling ready and anxiety disorders and a 25 percent decrease in likeliness for solidity abuse, according to a paper in the July outflow of Archives of General Psychiatry.

About 31 percent of all U.S. adults were obese in 2000, an increase from 23 percent in 1990, according to background information in the article. Obese adults are at higher risk of diabetes, cardiovascular disease and other harmful conditions. Previous studies have suggested a link between obesity and depression, but little research has examined the associations between obesity and other psychiatric disorders.

Gregory E. Simon, M.D., M.P.H., of the Group Health Cooperative, Seattle, and colleagues studied 9,125 adults from across the country who were interviewed as part of a large national survey of mental disorders between Feb. 5, 2001, and Feb. 12, 2003. Participants (average age 44.8 years) completed an in-home interview that included questions about demographic characteristics, height, weight and psychiatric disorders. These included mood disorders, such as major depression, dysthymia (persistent mild depression with associated symptoms) and bipolar disorder; anxiety disorders, such as panic disorder and generalized anxiety disorder; and substance abuse disorders, including alcohol or drug dependence.

Of all the participants, 6,795 had a body mass index (BMI) of less than 30 and 2,330 had a BMI of 30 or greater and were therefore considered obese. Those who were obese had a higher prevalence of mood and anxiety disorders and a lower prevalence of substance abuse disorders over their lifetimes. These associations remained similar for men and women. The link between obesity and mood disorders appeared strongest in non-Hispanic whites and in those with higher education levels.

“The estimated prevalence of lifetime mood disorder in those with BMIs below 30 and in those with BMIs 30 or higher translates to a population-attributable risk of 24 percent, which indicates that nearly one-quarter of the cases of obesity in the general population are attributable to the association with mood disorder,” the authors write. “This calculation illustrates the public health importance of the association but does not indicate a direction for the causal relationship. It is equally correct to state that more than one-fifth of cases of mood disorder in the general population are attributable to the association with obesity.” Increased appetite, weight gain, reduced physical activity and binge eating have all been associated with depression, potentially increasing risk for obesity. However, obesity could also contribute to depression by limiting physical activity, or through the stigma that may be associated with being overweight, especially among some women and other particular sociodemographic groups. An unknown third cause also could be linked to both. The results also do not indicate the mechanisms behind the negative association between obesity and substance abuse.

“We conclude that obesity is meaningfully associated with a range of common mood and anxiety disorders in the general U.S. population,” the authors write. “Obesity is associated with a moderately lower risk of substance use disorder. Variation in the obesity-depression relationship by education level and race/ethnicity suggests an important role of social or cultural factors in mediating or moderating the relationship between obesity and mood disorders.”

http://archpsyc.ama-assn.org/

According to a new study older people who have difficulty identifying common odors may be more at risk of developing problems with thinking, erudition and honour.

Experts say mild cognitive impairment, a decline in thinking, learning and memory is recognized as a precursor to Alzheimer’s disease and a weakened sense of smell could be a sign of the disease.

The study by Dr. Robert Wilson at Rush University Medical Center, Chicago, and colleagues suggests that a difficulty in identifying odors predicts the development of mild cognitive impairment and could be a useful tool for early disease identification.

The study began in 1997 and examined 589 older adults with an average age of 79 who did not have cognitive impairment.

They were given a smell identification test where 12 familiar odors - onion, lemon, cinnamon, black pepper, chocolate, rose, banana, pineapple, soap, paint thinner, gasoline and smoke - were placed under their nose and they were asked to match each odor to one of four possible alternatives.

The participants underwent a clinical evaluation that included a medical history, neurological examination and testing of their cognitive function at the start of the study and again every year for up to five years.

The researchers found that 177 individuals developed mild cognitive impairment and the risk increased as odor identification decreased.

This association remained even when factors such as stroke, smoking habits or other factors that might influence smell or cognitive ability were considered.

Currently there is no cure for Alzheimer’s disease, which affects more than 5 million Americans, but early diagnosis and intervention can slow down the progress and help manage the symptoms that are associated with the disease.

Experts say that microscopic lesions are present in the very early stages of the disease and on the basis of anatomy the findings are logical.

The research could in future lead to a sniff test for the early signs of the devastating disease.

The study was funded by the National Institute on Aging and the Illinois Department of Public Health and is published in the current issue of the Archives of General Psychiatry, one of the JAMA/Archives journals.

Prevention of malaria for persons who travel in support of more than 6 months is complex and should be individualized, with notice from travel medicine specialists, according to a reassess article in the November 8 issue of JAMA.

There were more than 800 million trips by travelers worldwide in 2005, according to qualifications information in the article. For long-administration conditions travelers visiting malaria-endemic countries, recommendations for bar have been dark to standardize due to the multifariousness of long-term travelers and their itineraries, the modification in the mark of and access to medical anguish, the restricted figures on malaria frequency in travelers overseas, and the be of controlled studies on long-term refuge and effectiveness of antimalarial agents. Favour complicating the recommendations is the growth in the intensity of dispatching and guerillas patterns of the malaria parasites, the seasonality of transmission, and the all the way range of global guidelines and travelers’ beliefs and expectations.

Lin H. Chen, M.D., of Mount Auburn Facility, Cambridge, Mass., and colleagues conducted a review of relevant studies and articles, published through July 2006, to examine the risk of malaria in hanker-term travelers, recent developments in intimate protective measures, and the safety and tolerability of malaria treatments during great-term exploit and to judge prevention strategies.

The studies indicated that long-term travelers (more than 6 months) attired in b be committed to a higher risk of malaria than short-term travelers. “Long-semester travelers underuse personal protective measures and adhere rotten to persistent chemoprophylaxis regimens. A several of strategies are used during long-term stays: discontinuation of chemoprophylaxis after the initial period, organized regimens with bizarre medications for chemoprophylaxis, accept-by danger self-treatment, and seasonal chemoprophylaxis targeting high-rate periods or locations. All strategies have advantages and drawbacks,” the researchers write.

The authors add that vivax malaria (a form of malaria marked by convulsions that occur every 48 hours and caused by the bloodsucker Plasmodium vivax) causes significant illness in travelers, but relapses of vivax malaria are not prevented with the latest first-line chemoprophylaxis regimens.

“Long-articles travelers to malaria-endemic areas brass risk of death, morbidity, and reduced productivity because of malaria. All-inclusive guidelines are plummy, but recommendations for malaria prevention in long-term travelers should be individualized and should be provided by fraternize medicine specialists. Personal protective measures are cardinal. Indication of reliable medical facilities at destination is crucial for long-term travelers regardless of their malaria proscribing strategies, and a add up of resources are readily obtainable to aid in this process. Statistics on protection of chemoprophylaxis drugs show sound clinical support for long-term profit by, particularly recompense mefloquine.”

“All travelers should be advised to at or form fair to middling supplies of antimalarial agents, because counterfeit drugs are rampant in developing countries. Extensive-term travelers should also consider evacuation indemnification for medical emergencies,” they put in black. “Presumptive antirelapse therapy should be considered for extensive-term travelers who have been intensively exposed to P vivax. Because inconsistent recommendations undermine the adherence to any preventive strategy, country-wide and supranational experts should fight toward consensus on guidelines for malaria prevention in long-designate travelers.”

—————————-
Article adapted by Medical News Today from original press release.
—————————-

(JAMA. 2006;296:2234-2244.)

Please see the article as additional information, including other authors, author contributions and affiliations, financial disclosures, funding and bear out, etc.

Conjunction: Kelly Kass
JAMA and Archives Journals

Members of the vascular community held many heated debates at this year’s VEITHsymposium. One of the scads points of argument was
whether new studies comparing carotid endarterectomy (CAE) and carotid artery stenting (CAS) should include a third arm, studying
the effects of best medical treatment (BMT).

While physicians on either side exhibit details to support their claims, with Dr. Allison
Halliday of St. Georges Hospital Medical School and Epsom and St. Helier Hospitals in London as the primary rival in favour of adding the
third arm and Dr. Peter Bell of the University of Leicester and the Leicester Viscountess Infirmary (UK) and Dr. John Rundbeck of the
Columbia University College of Physicians and Surgeons arguing strongly on the side of including the third arm, a show-of-hands unconstrained receive
enchanted from the filled ballroom of physicians showed that the more than half was in favor of adding the third arm to trials, solely in light
of the successes shown recently in the use of statins as for as a method of treatment for forms of vascular disease.

Another hot-button topic was whether or not CAS could be done safely in patients once again the age of 75 or if those patients would be
safer served with CAE, with Dr. Amor of the University of Drug of Nancy, France, arguing for the sake it and Dr. Bruce Perler of Johns
Hopkins strongly arguing against the services of the procedure in octogenarians. Another easy survey (of the mostly surgeon-filled room)
gave Dr. Perler a strong win.

VEITH SYMPOSIUM - New York, November 19th to 23rd

Instanter in its fourth decade, VEITH SYMPOSIUM provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a sui generis and exciting format to learn the most current news not far from what is new and important in the treatment of vascular disease. The 5-day happening features rapid-inspired presentations from world renowned vascular specialists with importance on the latest advances, changing concepts in diagnosis and direction, pivotal controversies and new techniques.

VEITHsymposium is sponsored by Cleveland Clinic, Cleveland, OH.

www.veithsymposium.org

Origin
Pauline T. Mayer
www.ptmhcm.com

UroToday.com- A study from Pape, et al evaluated a matched benefactress pool for pediatric patients by age. There are some allocation systems in existence today that have a mandatory donation of pediatric kidney allocation to children while others do not. Both allocation systems have medical and organizational advantages and disadvantages for both adults and children.

The group inaugurate that matchless seniority-matched kidney allocation to children was beneficial. There seems to be higher long-term glomerular filtration rates and splice survival afterwards, a lesser call on dialysis. They also set up that there is a better psychosocial rehabilitation as well as better advance and maturing of children who had aged matched kidneys and that there may be a likely bourgeon of the donor pool.

Overall the group felt that health protection costs would be reduced for children with end-stage renal non-performance because of this quintessence of donor pool. They also state it will-power from a minimal impact on the full-grown inhabitants. They recommend an majority-matched allocation program in children with end- stage renal disease to offer a better prognosis.

Pape L, Ehrich JHH and Offner G

Pediatric Nephrology. 22(4):477-479, April 2007.
Doi: 10.1007/s00467-006-0350-9

Reported by UroToday.com Contributing Redactor Pasquale Casale, M.D

UroToday - the solely urology website with original constituents written by universal urology key opinion leaders actively engaged in clinical application.

To access the latest urology news releases from UroToday, go to:
www.urotoday.com

—————————-
Copyright © 2007 - UroToday
Reproduced looking for Medical Statement Today with permission of UroToday.
—————————-

Two groups from INSERM and Institut Gustave Roussy collaborated to conduct an epidemiologic study on a cohort of French women members of the Mutuelle generale de l’Education nationale (E3N). The scientists showed that the jeopardize of chest cancer was doubled in women having higher serum levels of trans fatty acids. The trans fatty acids intentional are those from industrial sources (processed foods, processed bread, processed pastries, cakes, potato chips, pizza dough, etc.).

Unlike Asian countries, where the jealous effect of omega-3 fatty acids from fish on knocker cancer hazard was clearly demonstrated, a protective more against heart cancer was not bring about in this retreat.

These results are published in the American Monthly of Epidemiology.

The E3N cohort is the French part of EPIC, a large European study coordinated by the International Workings for Research on Cancer (IARC), and involving 500 000 Europeans in 10 countries.

The unhealthy effects of trans fatty acids on cardiovascular imperil keep been well established since the early 1990s, anyhow their bump on breast cancer imperil remained to be elucidated. The teams of scientists from INSERM and Institut Gustave Roussy sought to quantify the role of various types of fatty acids on breast cancer advance, using blood samples collected between 1995 and 1998, amongst 25 000 of the 100 000 women followed up within the E3N den.

In order to assess the condition effects of human diet, scientists assayed various biomarkers of regime in the blood, and particularly fatty acid levels. Materials on 363 women diagnosed with bust cancer after blood sampling were analysed. Their serum fatty acid levels were then compared with those of breast cancer-unrestrained women controls. Two controls were matched to each breast cancer case, for a total of 702 women.

Near-doubling of risk

The dissection of trans and cis fatty acids showed that mamma cancer jeopardize increases with the increase in trans fatty acid level, reflecting processed rations consumption. These results screen that women with elevated serum levels of trans fatty acid have almost twice the imperil of developing breast cancer, compared to women with the lowest levels. “At this the boards, we can just endorse limiting the consumption of processed foods, the well-spring of industrially-produced trans fatty acid. Notably, industrial processes generating trans fatty acids (partially hydrogenated vegetable oils) still in use should be curbed, as this has been undertaken in Denmark for a two years. As far as regulations on labeling of processed products, the content in trans fatty acids should be positively indicated”, the report concluded.

Protective effect of omega-3 fatty acids for knocker cancer not worldwide

Also, the authors of the study confirmed the results of other studies conducted in North American and European countries concerning the scantiness of association between omega-3 fatty acid serum levels, as far as something which the vital dietary start is the intake of fish, and risk of breast cancer. While a protective achieve of omega-3 fatty acids on breast cancer risk was clearly demonstrated in Asian countries, where fish consumption is much higher than in Europe or in North America, this defensive purport could not be dignified in this much-powered French study, probably due to considerably lower per-capita consumption of fish.

In industrialised countries, breast cancer is the most common cancer in women. According to the authors of the study, among the risk factors that may advance themselves to train prevention, subsistence shows strong budding, as a single but consistent change in dietary habits could lower the risk of heart of hearts cancer, subject to clear identification of responsible nutrients. Among those, dietary lipids could play a major role. Further analysis from the EPIC study longing therefore trial the supposition of a lines for trans fatty acids in carcinogenesis in a population with wide variations in the intake of those fatty acids, come up to b become other lipids.

The E3n Study

E3N, an epidemiologic inspect conducted on women members of the MGEN (French Chauvinistic Schooling workers complementary medical insurance scheme) led by Dr Françoise Clavel-Cahpelon (INSERM-Gustave Roussy), is a prospective cohort study of about 100 000 volunteer French women born between 1925 and 1950, and followed up since 1990.

Data on their lifestyle factors (diet, hormonal treatments, etc.) and their health stature were collected by self-administered questionnaire every other year since 1990. These facts were complemented by biological measurements, obtained for the benefit of 25 000 volunteers, from a blood specimen charmed for later analysis (case-control studies nested within the cohort). E3N gives predominant baksheesh to breast and colorectal cancers, due to their high rate rates.

Source

Serum trans-monounsaturated fatty acids are associated with an increased risk of breast cancer in the E3N-EPIC Ruminate on.
V. Chajès; A. C.M. Thiébaut; M. Rotival; E. Gauthier ; V. Maillard; M.C. Boutron-Ruault; V. Joulin; G. M. Lenoir ; F. Clavel-Chapelon.
Am. J. Epidemiol. 2008 (DOI: 10.1093/aje/kwn069)

Supranational Operation for Scrutinization on Cancer